Anti-inflammatory activity of iridoid and catechol derivatives from Eucommia ulmoides Oliver

ACS Chemical Neuroscience

Volumn 5, Issue 9, 2014, Pages 855-866

  Luo, Dan ^a   Or, Terry C T ^a   Yang, Cindy L H ^a   Lau, Allan S Y ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

4 (1,2 dimethoxyethyl)benzene 1,2 diol; Eucommia ulmoides Oliver; Genipin; Neurodegenerative diseases; Neuroinflammation

Indexed keywords

4 (1,2 DIMETHOXYETHYL)BENZENE 1,2 DIOL; ANTIINFLAMMATORY AGENT; CATECHOL DERIVATIVE; DU ZHONG; GENIPIN; HYDROCORTISONE; IRIDOID; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CATECHOL; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRITE; PLANT MEDICINAL PRODUCT;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG PURIFICATION; EUCOMMIA ULMOIDES; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PLANT LEAF; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEPARATION TECHNIQUE; SIGNAL TRANSDUCTION; SPECTROSCOPY; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; EUCOMMIACEAE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROGLIA; NUCLEAR MAGNETIC RESONANCE IMAGING; TRANSFORMED CELL LINE;

EUCOMMIA ULMOIDES;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CATECHOLS; CELL LINE, TRANSFORMED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; EUCOMMIACEAE; GENE EXPRESSION REGULATION; IRIDOIDS; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE IMAGING; MICE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PHOSPHATIDYLINOSITOL 3-KINASES; PLANT PREPARATIONS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84908571400     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn5001205     Document Type: Article

References (70)

1. Skaper, S. D., Giusti, P., and Facci, L. (2012) Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J. 26, 3103-3117.
2. McGeer, P. L., Itagaki, S., Boyes, B. E., and McGeer, E. G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1291.
3. Aloisi, F. (2001) Immune function of microglia. Glia 36, 165-179.
4. Lucas, S. M., Rothwell, N. J., and Gibson, R. M. (2006) The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (Suppl 1), S232-240.
5. Zielasek, J., and Hartung, H. P. (1996) Molecular mechanisms of microglial activation. Adv. Neuroimmunol. 6, 191-122.
6. Kaur, C., and Ling, E. A. (2009) Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Prog. Neurobiol. 87, 264-280.
7. Andrew, P. J., and Mayer, B. (1999) Enzymatic function of nitric oxide synthases. Cardiovasc. Res. 43, 521-531.
8. Pannu, R., and Singh, I. (2006) Pharmacological strategies for the regulation of inducible nitric oxide synthase: Neurodegenerative versus neuroprotective mechanisms. Neurochem. Int. 49, 170-182.
9. Wang, P. H., and Zweier, J. L. (1996) Measurement of nitric oxide and peroxynitrite generation in the postischemic heart - Evidence for peroxynitrite-mediated reperfusion injury. J. Biol. Chem. 271, 29223-29230.
10. Radi, R., Cassina, A., and Hodara, R. (2002) Nitric oxide and peroxynitrite interactions with mitochondria. Biol. Chem. 383, 401-409.
11. Tweedie, D., Sambamurti, K., and Greig, N. H. (2007) TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: New drug candidates and targets. Curr. Alzheimer Res. 4, 378-385.
12. Montgomery, S. L., and Bowers, W. J. (2012) Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System. J. Neuroimmune Pharmacol. 7, 42-59.
13. McGeer, P. L., and McGeer, E. G. (2002) Local neuroinflammation and the progression of Alzheimer's disease. J. Neuro Virol. 8, 529-538.
14. Yang, G. Y., Gong, C., Qin, Z., Ye, W., Mao, Y., and Bertz, A. L. (1998) Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. NeuroReport 9, 2131-2134.
15. Barone, F. C., and Feuerstein, G. Z. (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819-834.
16. Tian, D., Litvak, V., and Lev, S. (2000) Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells. J. Neurosci. 20, 6478-6487.
17. Walton, K. M., DiRocco, R., Bartlett, B. A., Koury, E., Marcy, V. R., Jarvis, B., Schaefer, E. M., and Bhat, R. V. (1998) Activation of p38(MAPK) in microglia after ischemia. J. Neurochem. 70, 1764-1767.
18. Lee, M., McGeer, E., Kodela, R., Kashfi, K., and McGeer, P. L. (2013) NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: A new candidate for treatment of neurodegenerative disorders. Glia 61, 1724-1734.
19. Legos, J. J., Erhardt, J. A., White, R. F., Lenhard, S. C., Chandra, S., Parsons, A. A., Tuma, R. F., and Barone, F. C. (2001) SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Res. 892, 70-77.
20. Barone, F. C., Irving, E. A., Ray, A. M., Lee, J. C., Kassis, S., Kumar, S., Badger, A. M., White, R. F., McVey, M. J., Legos, J. J., Erhardt, J. A., Nelson, A. H., Ohlstein, E. H., Hunter, A. J., Ward, K., Smith, B. R., Adams, J. L., and Parsons, A. A. (2001) SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J. Pharmacol. Exp. Ther. 296, 312-321.
21. Schaeffer, V., Arbabi, S., Garcia, I. A., Knoll, M. L., Cuschieri, J., Bulger, E. M., and Maier, R. V. (2011) Role of the mTOR Pathway in LPS-Activated Monocytes: Influence of Hypertonic Saline. J. Surg. Res. 171, 769-776.
22. Pacher, P., Beckman, J. S., and Liaudet, L. (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424.
23. Wang, Q., Tang, X. N., and Yenari, M. A. (2007) The inflammatory response in stroke. J. Neuroimmunol. 184, 53-68.
24. Buss, H., Schmitz, L., Dorrie, A., Resch, K., and Kracht, M. (2002) Characterisation of protein kinases targeting p65 NF-KB phosphorylation and transactivation. Naunyn-Schmiedeberg's Arch. Pharmacol. 365, R56-R56.
25. Stone, J., Carson, A., Duncan, R., Roberts, R., Warlow, C., Hibberd, C., Coleman, R., Cull, R., Murray, G., Pelosi, A., Cavanagh, J., Matthews, K., Goldbeck, R., Smyth, R., Walker, J., and Sharpe, M. (2010) Who is referred to neurology clinics? The diagnoses made in 3781 new patients. Clin. Neurol. Neurosurg. 112, 747-751.
26. Lang, C., Liu, Z., Taylor, H. W., and Baker, D. G. (2005) Effect of Eucommia ulmoides on systolic blood pressure in the spontaneous hypertensive rat. Am. J. Chin. Med. 33, 215-230.
27. Freis, E. D., Ragan, D., Pillsbury, H., 3rd, and Mathews, M. (1972) Alteration of the course of hypertension in the spontaneously hypertensive rat. Circ. Res. 31, 1-7.
28. Liu, E., Han, L., Wang, J., He, W., Shang, H., Gao, X., and Wang, T. (2012) Eucommia ulmoides bark protects against renal injury in cadmium-challenged rats. J. Med. Food 15, 307-314.
29. Park, S. A., Choi, M. S., Jung, U. J., Kim, M. J., Kim, D. J., Park, H. M., Park, Y. B., and Lee, M. K. (2006) Eucommia ulmoides Oliver leaf extract increases endogenous antioxidant activity in type 2 diabetic mice. J. Med. Food 9, 474-479.
30. Scatena, R., Martorana, G. E., Bottoni, P., Botta, G., Pastore, P., and Giardina, B. (2007) An update on pharmacological approaches to neurodegenerative diseases. Expert Opin. Invest. Drugs 16, 59-72.
31. Lleo, A., Greenberg, S. M., and Growdon, J. H. (2006) Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 57, 513-533.
32. Sarker, S. D., Latif, Z., and Gray, A. I. (2006) Natural Products Isolation, Human Press Inc., Clifton, NJ.
33. Lelono, R. A., Tachibana, S., and Itoh, K. (2009) Isolation of antifungal compounds from Gardenia jasminoides. Pak. J. Biol. Sci. 12, 949-956.
34. Mi, F. L. (2005) Synthesis and characterization of a novel chitosan-gelatin bioconjugate with fluorescence emission. Biomacromolecules 6, 975-987.
35. Mailloux, R. J., Adjeitey, C. N., and Harper, M. E. (2010) Genipin-induced inhibition of uncoupling protein-2 sensitizes drug-resistant cancer cells to cytotoxic agents. PLoS One 5, e13289.
36. Suzuki, Y., Kondo, K., Ikeda, Y., and Umemura, K. (2001) Antithrombotic effect of geniposide and genipin in the mouse thrombosis model. Planta Med. 67, 807-810.
37. Tanaka, M., Yamazaki, M., and Chiba, K. (2009) Neuroprotective action of genipin on tunicamycin-induced cytotoxicity in neuro2a cells. Biol. Pharm. Bull. 32, 1220-1223.
38. Goto, H., and Takikawa, H. (2010) Effect of genipin on cholestasis induced by estradiol-17beta-glucuronide and lithocholate-3-O-glucuornide in rats. Hepatol. Res. 40, 524-529.
39. Lin, C. H., Chang, T. T., Sun, M. F., Chen, H. Y., Tsai, F. J., Chang, K. L., Fisher, M., and Chen, C. Y. (2011) Potent inhibitor design against H1N1 swine influenza: Structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database. J. Biomol. Struct. Dyn. 28, 471-482.
40. Koo, H. J., Song, Y. S., Kim, H. J., Lee, Y. H., Hong, S. M., Kim, S. J., Kim, B. C., Jin, C., Lim, C. J., and Park, E. H. (2004) Antiinflammatory effects of genipin, an active principle of gardenia. Eur. J. Pharmacol. 495, 201-208.
41. Hwa, J. S., Mun, L., Kim, H. J., Seo, H. G., Lee, J. H., Kwak, J. H., Lee, D. U., and Chang, K. C. (2011) Genipin Selectively Inhibits TNF-alpha-activated VCAM-1 But Not ICAM-1 Expression by Upregulation of PPAR-gamma in Human Endothelial Cells. Korean J. Physiol. Pharmacol. 15, 157-162.
42. Nam, K. N., Choi, Y. S., Jung, H. J., Park, G. H., Park, J. M., Moon, S. K., Cho, K. H., Kang, C., Kang, I., Oh, M. S., and Lee, E. H. (2010) Genipin inhibits the inflammatory response of rat brain microglial cells. Int. Immunopharmacol. 10, 493-499.
43. Zheng, L. T., Ryu, G. M., Kwon, B. M., Lee, W. H., and Suk, K. (2008) Anti-inflammatory effects of catechols in lipopolysaccharides-timulated microglia cells: inhibition of microglial neurotoxicity. Eur. J. Pharmacol. 588, 106-113.
44. Heneka, M. T., Nadrigny, F., Regen, T., Martinez-Hernandez, A., Dumitrescu-Ozimek, L., Terwel, D., Jardanhazi-Kurutz, D., Walter, J., Kirchhoff, F., Hanisch, U. K., and Kummer, M. P. (2010) Locus ceruleus controls Alzheimer ' s disease pathology by modulating microglial functions through norepinephrine. Proc. Natl. Acad. Sci. U.S.A. 107, 6058-6063.
45. Chalermpalanupap, T., Kinkead, B., Hu, W. T., Kummer, M. P., Hammerschmidt, T., Heneka, M. T., Weinshenker, D., and Levey, A. I. (2013) Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease. Alzheimer's Res. Ther. 5, 21.
46. Kaneko, Y. S., Mori, K., Nakashima, A., Sawada, M., Nagatsu, I., and Ota, A. (2005) Peripheral injection of lipopolysaccharide enhances expression of inflammatory cytokines in murine locus coeruleus: Possible role of increased norepinephrine turnover. J. Neurochem. 94, 393-404.
47. Tintinger, G. R., Theron, A. J., Anderson, R., and Ker, J. A. (2001) The anti-inflammatory interactions of epinephrine with human neutrophils in vitro are achieved by cyclic AMP-mediated accelerated resequestration of cytosolic calcium. Biochem. Pharmacol. 61, 1319-1328.
48. Jan, B. U., Coyle, S. M., Oikawa, L. O., Lu, S. E., Calvano, S. E., Lehrer, P. M., and Lowry, S. F. (2009) Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: A randomized controlled trial. Ann. Surg. 249, 750-756.
49. Lipsanen, A., and Jolkkonen, J. (2011) Experimental approaches to study functional recovery following cerebral ischemia. Cell. Mol. Life Sci. 68, 3007-3017.
50. Park, E. K., Rhee, H. I., Jung, H. S., Ju, S. M., Lee, Y. A., Lee, S. H., Hong, S. J., Yang, H. I., Yoo, M. C., and Kim, K. S. (2007) Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation. Phytother. Res. 21, 746-750.
51. Nakaso, K., Ito, S., and Nakashima, K. (2008) Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci. Lett. 432, 146-150.
52. Jia, Y., Mo, S. J., Feng, Q. Q., Zhan, M. L., Ouyang, L. S., Chen, J. C., Ma, Y. X., Wu, J. J., and Lei, W. L. (2014) EPO-Dependent Activation of PI3K/Akt/FoxO3a Signalling Mediates Neuroprotection in In Vitro and In Vivo Models of Parkinson's Disease. J. Mol. Neurosci. 53, 117-124.
53. Rickle, A., Bogdanovic, N., Volkman, I., Winblad, B., Ravid, R., and Cowburn, R. F. (2004) Akt activity in Alzheimer's disease and other neurodegenerative disorders. NeuroReport 15, 955-959.
54. Kim, W. K., Hwang, S. Y., Oh, E. S., Piao, H. Z., Kim, K. W., and Han, I. O. (2004) TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J. Immunol. 172, 7015-7023.
55. Jhun, B. S., Jin, Q., Oh, Y. T., Kim, S. S., Kong, Y., Cho, Y. H., Ha, J., Baik, H. H., and Kang, I. (2004) 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem. Biophys. Res. Commun. 318, 372-380.
56. Lee, J. Y., Jhun, B. S., Oh, Y. T., Lee, J. H., Choe, W., Baik, H. H., Ha, J., Yoon, K. S., Kim, S. S., and Kang, I. (2006) Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NFkappaB activation in murine BV2 microglial cells. Neurosci. Lett. 396, 1-6.
57. Xing, B., Xin, T., Hunter, R. L., and Bing, G. (2008) Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J. Neuroinflammation 5, 4.
58. Kim, H. G., Shrestha, B., Lim, S. Y., Yoon, D. H., Chang, W. C., Shin, D. J., Han, S. K., Park, S. M., Park, J. H., Park, H. I., Sung, J. M., Jang, Y., Chung, N., Hwang, K. C., and Kim, T. W. (2006) Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur. J. Pharmacol. 545, 192-199.
59. Pan, M. H., Lai, C. S., Wang, Y. J., and Ho, C. T. (2006) Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem. Pharmacol. 72, 1293-1303.
60. Ghigo, A., Damilano, F., Braccini, L., and Hirsch, E. (2010) PI3K inhibition in inflammation: Toward tailored therapies for specific diseases. BioEssays 32, 185-196.
61. Yang, C. L., Chik, S. C., Li, J. C., Cheung, B. K., and Lau, A. S. (2009) Identification of the bioactive constituent and its mechanisms of action in mediating the anti-inflammatory effects of black cohosh and related Cimicifuga species on human primary blood macrophages. J. Med. Chem. 52, 6707-6715.
62. Or, T. C., Yang, C. L., Law, A. H., Li, J. C., and Lau, A. S. (2011) Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia. Neuropharmacology 60, 823-831.
63. Wang, L., Yang, C. L., Or, T. C., Chen, G., Zhou, J., Li, J. C., and Lau, A. S. (2011) Differential effects of Radix Paeoniae Rubra (Chishao) on cytokine and chemokine expression inducible by mycobacteria. Chin. Med. 6, 14.
64. Marks, D. C., Belov, L., Davey, M. W., Davey, R. A., and Kidman, A. D. (1992) The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leuk. Res. 16, 1165-1173.
65. Sreejayan, and Rao, M. N. (1997) Nitric oxide scavenging by curcuminoids. J. Pharm. Pharmacol. 49, 105-107.
66. Or, T. C. T., Yang, C. L. H., Law, A. H. Y., Li, J. C. B., and Lau, A. S. Y. (2011) Isolation and identification of anti-inflammatory constituents from Ligusticum chuanxiong and their underlying mechanisms of action on microglia. Neuropharmacology 60, 823-831.
67. Cheung, B. K. W., Yim, H. C. H., Lee, N. C. M., and Lau, A. S. Y. (2009) A novel anti-mycobacterial function of mitogen-activated protein kinase phosphatase-1. BMC Immunol. 10, 64.
68. Kunert-Keil, C., Bisping, F., Kruger, J., and Brinkmeier, H. (2006) Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics 7, 159.
69. Niu, J., Azfer, A., Wang, K., Wang, X., and Kolattukudy, P. E. (2009) Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice. J. Pharmacol. Exp. Ther. 328, 740-748.
70. Lee, D. C. W., Cheung, C. Y., Law, A. H. Y., Mok, C. K. P., Peiris, M., and Lau, A. S. Y. (2005) p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J. Virol. 79, 10147-10154.